A detailed history of High Vista Strategies LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, High Vista Strategies LLC holds 115,326 shares of ROIV stock, worth $1.38 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
115,326
Previous 126,741 9.01%
Holding current value
$1.38 Million
Previous $1.34 Million 0.67%
% of portfolio
0.52%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.17 - $12.5 $116,090 - $142,687
-11,415 Reduced 9.01%
115,326 $1.33 Million
Q2 2024

Aug 14, 2024

SELL
$10.36 - $11.74 $884,505 - $1 Million
-85,377 Reduced 40.25%
126,741 $1.34 Million
Q1 2024

May 15, 2024

BUY
$9.87 - $11.8 $1.55 Million - $1.85 Million
157,188 Added 286.16%
212,118 $2.24 Million
Q4 2023

Feb 14, 2024

BUY
$8.38 - $11.58 $460,313 - $636,089
54,930 New
54,930 $616,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.